Date | Time | Source | Headline | Symbol | Company |
20/04/2017 | 20:04 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
14/03/2017 | 07:37 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
06/03/2017 | 22:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
03/03/2017 | 07:57 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
03/03/2017 | 07:55 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
03/03/2017 | 07:51 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
03/03/2017 | 03:32 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
02/03/2017 | 09:04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
02/03/2017 | 08:56 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
02/03/2017 | 08:50 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
02/03/2017 | 07:36 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
02/03/2017 | 04:32 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
02/03/2017 | 04:30 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
02/03/2017 | 04:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
02/03/2017 | 04:21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
02/03/2017 | 04:19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
02/03/2017 | 04:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
02/03/2017 | 04:15 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
02/03/2017 | 04:13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
02/03/2017 | 04:13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
02/03/2017 | 01:52 | PR Newswire (US) | Lilly Completes Acquisition of CoLucid Pharmaceuticals | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
02/03/2017 | 01:41 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
02/03/2017 | 00:45 | PR Newswire (US) | Lilly Completes Acquisition of CoLucid Pharmaceuticals | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
01/03/2017 | 22:31 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
01/03/2017 | 22:18 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
15/02/2017 | 04:33 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
15/02/2017 | 03:58 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
15/02/2017 | 03:15 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
11/02/2017 | 08:32 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
11/02/2017 | 07:39 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |